Ізраїль -
іврит -
Ministry of Health
asala - ג'ל אל סבון (שלב i לעור שמן עם פצעונים)
תעשיות חלאבין בעמ - ניקוי פנים
Ізраїль -
іврит -
Ministry of Health
פנטסה חוקן
ferring pharmaceuticals ltd - mesalazine - חוקן - mesalazine 1 g / 100 ml - aminosalicylic acid and similar agents - ulcerative colitis - chron's disease
Ізраїль -
іврит -
Ministry of Health
אימוראן טבליות 25 מג
padagis israel agencies ltd, israel - azathioprine - טבליות מצופות פילם - azathioprine 25 mg - azathioprine - azathioprine - immunosuppressive agent used in transplantation surgery for suppression of graft rejection. for special cases of rheumatoid arthritis- not responsive to other agents- and only by rheumatology experts in hospitals or rheumatic clinics.
Ізраїль -
іврит -
Ministry of Health
אימוראן טבליות 50 מג
padagis israel agencies ltd, israel - azathioprine - טבליות מצופות פילם - azathioprine 50 mg - azathioprine - azathioprine - immunosupressive agent used in transplantation surgery for suppression of graft rejection. for special cases of rheumatoid artritis, not responsive to other agents, and only by rheumatology experts in hospitals or rheumatic clinics.
Ізраїль -
іврит -
Ministry of Health
פוסאלאן פעם בשבוע 70 מג
organon pharma israel ltd., israel - alendronate as sodium - טבליה - alendronate as sodium 70 mg - alendronic acid - alendronic acid - fosalan is indicated for the treatment of osteoporosis in postmenopausal women to prevent fractures, including those of the hip and spine (vertebral compression fractures). treatment to increase bone mass in men with osteoporosis.
Ізраїль -
іврит -
Ministry of Health
אנברל אבקה וממס
pfizer pharmaceuticals israel ltd - etanercept - אבקה וממס להכנת תמיסה להזרקה - etanercept 25 mg/vial - etanercept - etanercept - * rheumatoid arthritis:enbrel is indicated for the treatment of active rhematoid arthritis in adults when the response to disease-modifying antirheumatic drugs (dmards) including methotrexate (unless contraindicated) has been inadequate.. enbrel can be used in combination with methotrexate in patients who do not respond adequately to methotrexate alone. reducing signs and symptoms and inhibiting the progression of structural damage in patients with moderately to severely active rheumatoid arthritis.enbrel, alone or in combination with methotrexate, has been shown to reduce the rate of progression of joint damage as measured by x-ray and to improve physical function.* polyarticular juvenile idiopathic arthritis: treatment of active polyarticular juvenile idiopathic arthritis in children and adolescents from the age of 2 years who have had an inadequate response to, or who have proved intolerant of, methotrexate. enbrel has not been studied in children aged less than 2 years.* psoriatic arthritistreatment of ac